SpaceX, Anthropic, and the Mega-IPO Wave: What It Actually Means for Your Canadian Index ETF

SpaceX is expected to begin trading on Nasdaq under the ticker SPCX on June 12, 2026. The headline numbers are enormous: roughly $75 billion raised, a target valuation of at least $1.8 trillion, and only about 4.3% of shares sold to the public.

For Canadian index investors, the important question is not whether SpaceX is exciting or overpriced. It is simpler: if you own a broad US or global ETF, when would your fund buy it, and how much would you actually own?

Update — June 5, 2026: S&P Dow Jones resolved its mega-cap consultation on June 4. Two things changed from this post’s original June 3 version. First, S&P left the S&P 500 rules unchanged (it declined to shorten seasoning or waive the float requirement), so VFV/XUS/ZSP-type funds will not add SpaceX until it clears the usual float, seasoning, and profitability tests — 2027 at the earliest. Second, the S&P Total Market Index adopted both the new market-cap eligibility test and a roughly five-business-day IPO fast-track, so XEQT and XUU now pick up SpaceX at essentially the same time as the CRSP path (VUN/VEQT), not months later. The sections below reflect the final rules.

TL;DR

• SpaceX is expected to list with only about 4.3% of shares freely tradeable, so index funds would weight it by a much smaller float-adjusted value, not by the full $1.8 trillion headline valuation.
• CRSP has already changed its rules, which likely puts SpaceX into VUN and the US sleeve of VEQT/VXC about five trading days after listing, because CRSP adds large IPOs off-cycle rather than waiting for a scheduled rebalance.
• S&P confirmed its new Total Market rule on June 4, and the same change gives the S&P Total Market Index its own off-cycle IPO fast-track (about five business days’ lead time), so XEQT and XUU should pick up SpaceX within roughly a week of listing, on a timeline close to VUN and VEQT rather than months later.
• S&P left the S&P 500 rules unchanged, so VFV, XUS, ZSP, and ZUE will not pick up SpaceX until it clears the 10% float, 12-month seasoning, and profitability tests, which points to 2027 at the earliest and is not guaranteed.
• Nasdaq-100 funds such as XQQ, QQC, ZNQ, and the US-listed QQQ could add SpaceX after about 15 trading days, but with a special cap tied to float-adjusted market cap.
• The initial position is likely small: roughly $12 per $10,000 in broad US market exposure, and around $70 per $10,000 in Nasdaq-100 exposure.
• CAGE would likely hold little or none, because its Avantis factor process tilts toward value and profitability rather than buying every index addition.

Why this IPO is different

SpaceX is not an empty hype story. It reported $18.7 billion in 2025 revenue, Starlink is a real business with millions of subscribers, and the company dominates global launch by a wide margin. Anthropic filed for its own IPO on June 1, 2026, and OpenAI is widely expected to follow later in the year, so the market is treating this as a broader mega-IPO wave rather than a one-off.

The caution case is also real, and worth taking seriously before you cheer the addition. SpaceX is targeting a valuation more than double Morningstar’s reported fair-value estimate of about $780 billion, posted a nearly $5 billion net loss in 2025, and now includes xAI and X after a roughly $250 billion merger that explains much of that loss. Its reported Anthropic compute agreement, signed only weeks before the IPO, carries a 90-day termination right, which makes that headline revenue less durable than it first appears. None of this makes SpaceX a bad company. It makes the price a genuine open question, which is exactly why how it enters your portfolio matters.

The most important structural fact is the float. SpaceX is expected to sell only about 4.3% of its shares to the public. That is tiny next to mature mega-caps like Microsoft, Nvidia, or Amazon, which float nearly all of their shares, and it means index inclusion would chase a very limited pool of available stock.

Which ETFs could buy SpaceX first?

Historically, new public companies had to season for months before major indexes would add them. That buffer existed to let trading settle and prevent indexes from chasing IPO hype. Several index providers have now changed those rules specifically for mega-cap IPOs, which is what speeds up SpaceX’s path into some funds, though not all of them, and not all at the same time.

CRSP US Total Market: VUN, VTI, VEQT, VXC

This is the clearest path. CRSP amended its methodology in April 2026 so a new IPO can become eligible after just five trading days if it passes the eligibility and investability screens, and CRSP adds those large IPOs off-cycle rather than making them wait for the next quarterly reconstitution.

The old screen required at least 10% free float, which SpaceX’s expected 4.3% would have failed outright. The new alternative test allows entry with roughly $3.3 billion in float-adjusted market capitalization instead, a bar SpaceX clears many times over.

Because CRSP weights by free float rather than total market cap, SpaceX would not enter at $1.8 trillion. It would enter near $77 billion of investable value, which is the single distinction that shapes everything below.

Likely timing for VUN holders: about five trading days after listing.

S&P Total Market: XEQT, XUU, ITOT, XGRO, XBAL

This path is now confirmed, and fast. On June 4, 2026, S&P Dow Jones finalized its consultation and changed the S&P Total Market Index rules: a company is eligible if it has an Investable Weight Factor of at least 0.10 (a 10% float) or a float-adjusted market cap of at least 10% of the 100th largest company in the index. SpaceX fails the float test but clears the new market-cap test easily, so it qualifies for the S&P Total Market Index, effective with the rule change on June 8, 2026.

Crucially, the same change gives the S&P Total Market Index, the S&P Completion Index, and the Dow Jones U.S. Total Stock Market Index an IPO fast-track: once S&P announces a qualifying IPO (assessed on the stock’s first-day closing price), it is added off-cycle with about five business days’ lead time, rather than waiting for the next quarterly rebalance. Because SpaceX meets the updated eligibility rule through the market-cap test, it is fast-track eligible. ITOT, the US-listed fund XEQT and XUU hold for their US exposure, tracks the index and so reflects that fast-track addition.

Likely timing for XEQT/XUU holders: roughly a week after listing via the S&P Total Market fast-track, essentially the same date as VUN’s CRSP timeline (likely the same day, give or take one).

Nasdaq-100: XQQ, QQC, ZNQ, QQQ

Nasdaq changed its rules effective May 1, 2026. A large IPO can now enter the Nasdaq-100 after 15 trading days if its market cap ranks in the top 40 of index companies, which SpaceX qualifies for easily on size alone.

Rather than screen out the tiny float, Nasdaq handles it with a weighting cap: a constituent’s weight is limited to the lesser of its full market cap or three times its float-adjusted market cap. At a 4.3% float, that cap binds hard, so SpaceX would count at roughly three times its float-adjusted value, about $230 billion, instead of the full $1.8 trillion. Because Nasdaq-100 funds hold a large pool of assets against that limited float, this is where the most concentrated forced buying is likely to land, and the cap loosens as the float grows later in the year.

Likely timing for XQQ, QQC, ZNQ, and QQQ holders: about 15 trading days after listing, likely early July.

S&P 500: VFV, XUS, ZSP, ZUE

The S&P 500 is the slowest path, which surprises people, since it is the index most Canadians picture first. The June 4 consultation result settled this: S&P left the S&P 500 criteria unchanged, stating that exceptions to the financial viability, seasoning, and IWF requirements should not be granted solely based on market capitalization. So the proposed shorter seasoning window did not happen.

That leaves SpaceX facing the full set of hurdles. It needs a float of at least 10% (its IWF starts around 4.3% and only crosses 10% as the lockups release later in 2026), a 12-month seasoning period (which runs to roughly June 2027 given a June 12 listing), and positive GAAP earnings over the most recent quarter and the trailing four quarters together (SpaceX reported a large 2025 loss). Even once it clears all of that, the index committee still decides, weighing sector balance and other factors.

Likely timing for VFV holders: 2027 at the earliest, contingent on SpaceX turning profitable, and not guaranteed.

Russell indexes

FTSE Russell has also been working on fast-entry rules for IPOs, but Russell exposure is less common in Canadian ETF portfolios than CRSP, S&P, or Nasdaq exposure. If you own a Russell-tracking fund, check the fund’s specific index and reconstitution schedule, since inclusion would likely land at a scheduled reconstitution rather than on a fast track.

The lockup matters

SpaceX’s float is not expected to stay at 4.3%. Most IPOs use a single 180-day lockup, but SpaceX built a staged release that opens up shares in steps through late 2026 and into 2027:

• Musk’s roughly 42% stake is locked for a full 366 days with no early release, so it stays off the market until around mid-2027.
• Other large pre-IPO investors, the “extended” group, are mostly locked until 2027 as well, with only a first 20% tranche expected to release on December 31, 2026.
• The 180-day pool, roughly 4.7 billion shares, is the group that drives the 2026 float expansion. It unlocks in stages: after Q2 earnings, at the 70/90/105/120/135-day marks, after Q3 earnings, and finally in full at the 180-day mark in December.

This matters because index weights track free float, not total shares. As more shares become tradeable through the year, an index fund’s required SpaceX weight rises even if the share price never moves. The table below isolates that effect.

The VUN weight column holds the share price flat at the $1.8 trillion valuation, which it certainly will not do in reality. The point is to isolate the float effect on its own: even with a frozen price, the staged unlocks alone take a VUN holder’s SpaceX weight from about 0.12% to roughly 1.2% over the back half of 2026, a tenfold increase driven purely by shares becoming tradeable. Whatever the price actually does, that float-driven ramp sits underneath it.

How much would you own?

Using the roughly $77 billion float-adjusted value at listing against a CRSP US Total Market around $64 trillion, the initial position is far smaller than the headline valuation implies.

These are rough first-day estimates, not targets. The all-in-one funds dilute the exposure because US equities are only part of the fund: VGRO holds a smaller US sleeve than VUN, and VBAL holds less equity overall, so each one’s SpaceX sliver is correspondingly thinner.

There is a counterintuitive lesson buried in this table. The simplest, most hands-off portfolios get SpaceX first. A one-fund VEQT or VUN holder picks it up within about a week through CRSP, while someone who deliberately bought VFV for focused S&P 500 exposure waits until 2027 at the earliest, if at all. The buy-the-whole-market-and-forget-it investor ends up holding the new economy before the S&P 500 purist does.

And even the largest of these positions is not portfolio-changing. The roughly $70 of SpaceX inside $10,000 of a Nasdaq-100 fund is small, and stays modest even after the float fully ramps. The reason it is worth understanding is not the dollar figure, it is the principle: “passive” index exposure still depends on rules that someone writes, and those rules just changed specifically to admit a company that loses billions and floats almost no shares.

What about all-in-one funds like XEQT and VEQT?

All-in-one funds are the default holding for a huge number of Canadian investors, so it is worth spelling out what actually happens inside them. They get SpaceX through their US sleeve like everything else, just diluted twice over.

The first dilution is geographic. XEQT and VEQT are globally diversified, and US equities are only part of the mix, roughly 40-45% of each fund. So a SpaceX weight of about 0.12% inside the US total-market sleeve works out closer to 0.05% of the whole fund once you account for the Canadian, international, and emerging-market sleeves that hold none of it. In dollar terms that is roughly $5 per $10,000, not $12.

The second dilution applies to the asset-allocation versions. XGRO and VGRO hold a bond sleeve alongside equities, and XBAL and VBAL hold more bonds still, so each step down the risk ladder shrinks the equity portion and the SpaceX sliver with it, from a few dollars in the growth funds to a dollar or two in the balanced ones.

There is also a timing detail worth knowing: XEQT and VEQT now land on very similar schedules. VEQT’s US sleeve tracks CRSP (through VUN/VTI), which adds large IPOs off-cycle within about five trading days. XEQT’s US sleeve tracks the S&P Total Market (through ITOT), which, under the June 2026 rule change, fast-tracks qualifying IPOs off-cycle with about five business days’ lead time. Because both clocks start from the same listing, the two should pick up SpaceX at essentially the same time, within about a week and very possibly the same day, rather than on dramatically different timelines.

The takeaway is not that all-in-ones are doing anything wrong. It is that the more diversified your single fund, the smaller and slower your SpaceX exposure, which is diversification working exactly as intended.

The CAGE exception

CAGE is the interesting outlier, because it is not a cap-weighted index tracker at all. It is an Avantis CIBC all-equity ETF that tilts toward value and profitability, screening for what it buys rather than holding everything an index hands it.

SpaceX at IPO is close to the opposite of what that screen rewards: expensive, unprofitable, and valued largely on growth, AI, and future optionality. A process built around value and profitability would likely exclude it or hold very little, at least until the fundamentals change.

That is not automatically better or worse than owning it. It is a different bet. A cap-weighted ETF takes whatever the market hands it, SpaceX included; a factor fund like CAGE deliberately passes on names that fail its screen. Which one you prefer depends on whether you want the whole market or a tilt away from exactly this kind of company, and this IPO is a clean illustration of that fork.

What this means for you

For most people, the honest answer is that you do not need to do anything. If you own the whole market through a broad index fund, a small SpaceX position is simply part of that bargain, the same way you already own hundreds of companies you have never thought about.

If you specifically do not want SpaceX exposure, the lever is your choice of index, not constant tinkering. Total-market and Nasdaq-100 funds are the most likely early buyers, S&P 500 funds are slower, and factor funds like CAGE may avoid it altogether. Pick the fund whose rules match what you want to own.

The one thing worth actually watching is the float, not the daily price. A small public float plus forced index demand is a setup for sharp moves in both directions, and because the staged unlocks expand the supply of shares throughout the year, both that supply and your fund’s position keep shifting. The first print is unlikely to be the fair price in either direction.

Frequently asked questions

When exactly will SpaceX be in my ETF?

VUN and the US sleeve of VEQT/VXC could see it about five trading days after listing, because CRSP adds large IPOs off-cycle. XEQT and XUU track the S&P Total Market through ITOT, and the June 2026 rule change gave that index its own off-cycle IPO fast-track of about five business days, so they should pick it up at essentially the same time, very possibly the same day. Nasdaq-100 funds could see it after about 15 trading days. VFV and other S&P 500 funds are the slowest: S&P kept the S&P 500 rules unchanged on June 4, so SpaceX is not eligible until it clears the 10% float, 12-month seasoning, and profitability tests, which points to 2027 at the earliest and is not guaranteed.

Did S&P change its rules to let SpaceX in?

Partly. On June 4, 2026, S&P finalized its mega-cap consultation. It changed the S&P Total Market Index so a giant company with a tiny float can qualify through a market-cap test (a float-adjusted market cap of at least 10% of the 100th largest company) instead of the 10% float requirement, and it added an off-cycle IPO fast-track of about five business days, which is why SpaceX enters that index quickly. But it explicitly declined to change the S&P 500, S&P MidCap 400, or S&P SmallCap 600, saying market cap alone should not earn an exception to the financial viability, seasoning, and IWF requirements. So the broad Total Market path opened up while the S&P 500 path stayed shut.

Why is the position so small if SpaceX is worth $1.8 trillion?

Because index funds generally weight by free float. At a 4.3% float, only about $77 billion of investable value gets spread across the index at listing, and that float, along with the weight, grows as the staged lockup releases more shares through late 2026.

Does my SpaceX position stay the same after it is added?

No, it grows over 2026. The 180-day pool of roughly 4.7 billion shares unlocks almost entirely by mid-December, and a first 20% slice of the extended investor group releases December 31, taking estimated free float to roughly 44% by year end, up from about 4% at listing. Musk’s roughly 42% stake stays locked until around mid-2027, so it does not add to the float in 2026. These figures are estimates and will firm up once SpaceX discloses final share counts at pricing.

Does this apply to Anthropic and OpenAI too?

Broadly, yes. The exact timing and weight would depend on each company’s float, valuation, index eligibility, and the final index rules in force when they list.

Should I buy SpaceX directly at the IPO instead?

That is a personal decision and beyond the scope of this article. The narrower point here is that you may get a small indirect position through index ETFs even if you never buy the stock directly.

I hold CAGE. Am I missing out?

Maybe, maybe not. CAGE would likely avoid or underweight SpaceX because of its value and profitability process. That helps if the IPO disappoints and hurts if SpaceX performs well, which is the tradeoff you accept with any factor tilt.

---

This article is for educational purposes only and is not financial advice. Index methodologies and IPO terms change; verify the latest details before making any decision. Figures for index weights and free float are estimates based on the share counts, valuation, and lockup percentages reported in SpaceX’s S-1/A as of June 2026. SpaceX has not disclosed the exact per-bucket share counts, and the IPO had not priced as of writing, so these numbers are current estimates and will be updated as more information becomes available, particularly at final pricing.

Want to see where this kind of US-listed exposure best fits across your accounts? Try the Asset Location Optimizer to think through which of your registered and non-registered accounts should hold it.

Sources

• Space Exploration Technologies Corp. Form S-1/A, filed June 1, 2026
• Anthropic: confidential draft S-1 submission announcement, June 1, 2026
• CRSP Market Indexes: changes to float shares investability screen
• Nasdaq-100 Index methodology changes FAQ, May 2026
• S&P Dow Jones Indices consultation on treatment of MegaCap companies, April 30, 2026
• S&P Dow Jones Indices: Consultation on Treatment of MegaCap Companies — Results, June 4, 2026
• CNBC: SpaceX blocked from early U.S. benchmark index entry as S&P reaffirms existing rules, June 5, 2026
• FTSE Russell: IPO fast entry enhancements for Russell US Indexes
• CIBC fund snapshot: Avantis CIBC All-Equity Asset Allocation ETF